fenoratio 100 100 mg kapsułki
123ratio sp. z o.o. - fenofibratum - kapsułki - 100 mg
fenoratio retard 250 mg kapsułki o przedłużonym uwalnianiu
123ratio sp. z o.o. - fenofibratum - kapsułki o przedłużonym uwalnianiu - 250 mg
norotic 3,0 mg/ml + 10,0 mg/ml + 0,9 mg/ml krople do uszu, zawiesina
norbrook laboratories ltd. - dexamethasoni acetas + clotrimazolum + marbofloxacinum - krople do uszu, zawiesina - 3,0 mg/ml + 10,0 mg/ml + 0,9 mg/ml - pies
dx2lek 20 mg/ml płyn na skórę
aflofarm farmacja polska sp. z o.o. - minoxidilum - płyn na skórę - 20 mg/ml
elzonris
stemline therapeutics b.v. - tagraxofusp - lymphoma - Środki przeciwnowotworowe - elzonris is indicated as monotherapy for the first-line treatment of adult patients with blastic plasmacytoid dendritic cell neoplasm (bpdcn).
imatinib actavis
actavis group ptc ehf - imatinib - leukemia, myelogenous, chronic, bcr-abl positive; precursor cell lymphoblastic leukemia-lymphoma; myelodysplastic-myeloproliferative diseases; hypereosinophilic syndrome; dermatofibrosarcoma - protein kinase inhibitors, antineoplastic agents - imatinib actavis is indicated for the treatment of: , paediatric patients with newly diagnosed philadelphia chromosome (bcr-abl) positive (ph+) chronic myeloid leukaemia (cml) for whom bone marrow transplantation is not considered as the first line of treatment;, paediatric patients with ph+ cml in chronic phase after failure of interferon-alpha therapy, or in accelerated phase or blast crisis;, adult patients with ph+ cml in blast crisis;, adult patients with newly diagnosed philadelphia chromosome positive acute lymphoblastic leukaemia (ph+ all) integrated with chemotherapy;, adult patients with relapsed or refractory ph+ all as monotherapy;, adult patients with myelodysplastic/myeloproliferative diseases (mds/mpd) associated with platelet-derived growth factor receptor (pdgfr) gene re-arrangements;, adult patients with advanced hypereosinophilic syndrome (hes) and/or chronic eosinophilic leukaemia (cel) with fip1l1-pdgfr rearrangement;, the treatment of adult patients with unresectable dermatofibrosarcoma protuberans (dfsp) and adult patients with recurrent and/or metastatic dfsp who are not eligible for surgery. efekt imatinib na wynik przeszczepienia szpiku kostnego nie jest określona. imatinib actavis is indicated for: , in adult and paediatric patients, the effectiveness of imatinib is based on overall haematological and cytogenetic response rates and progression-free survival in cml, on haematological and cytogenetic response rates in ph+ all, mds/mpd, on haematological response rates in hes/cel and on objective response rates in adult patients with unresectable and/or metastatic dfsp. doświadczenie z imatinibom u pacjentów z mds/jest msy, związanych z pdgfr genów permutacji-bardzo ograniczony. brak kontrolowanych badań wykazują kliniczną korzyść lub zwiększone tempo dla tych chorób.
aurovalsart 160 mg tabletki powlekane
aurovitas pharma polska sp. z o.o. - valsartanum - tabletki powlekane - 160 mg
aurovalsart 80 mg tabletki powlekane
aurovitas pharma polska sp. z o.o. - valsartanum - tabletki powlekane - 80 mg
imatinib apotex 100 mg tabletki powlekane
apotex europe b.v. - imatinibum - tabletki powlekane - 100 mg
alphalben 100 mg/ml zawiesina doustna
alpha-vet kft. - albendazolum - zawiesina doustna - 100 mg/ml - bydło; owca